Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Daniel Vitt
CEO | Chief Executive Officer | 55 | 01.01.17 |
Glenn Whaley
DFI | Director of Finance/CFO | 56 | 01.12.19 |
Hella Kohlhof
CTO | Chief Tech/Sci/R&D Officer | 51 | 01.01.17 |
Andreas Muehler
CTO | Chief Tech/Sci/R&D Officer | 60 | 01.08.16 |
Jessica Breu
IRC | Investor Relations Contact | - | - |
Patrick Walsh
PRN | Corporate Officer/Principal | 41 | 14.10.21 |
Inderpal Singh
LAW | General Counsel | 58 | 01.06.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Barclay Phillips
BRD | Director/Board Member | 61 | 19.11.19 |
Tamar Howson
BRD | Director/Board Member | 75 | 11.10.19 |
Jörg Neermann
BRD | Director/Board Member | 57 | 01.04.19 |
Daniel Vitt
CEO | Chief Executive Officer | 55 | 01.01.17 |
Duane Nash
CHM | Chairman | 53 | 01.01.19 |
Richard Rudick
BRD | Director/Board Member | 73 | 26.04.23 |
Monika Tornsen
BRD | Director/Board Member | 45 | 05.07.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 90 079 016 | 83 120 924 ( 92,28 %) | 0 | 92,28 % |
Unternehmenskontakt
Immunic, Inc.
1200 Avenue of the Americas Suite 200
10036, New York
+
http://www.immunic-therapeutics.comSektor
Umsatz je Region
% 1. Jan. | Kap. | |
---|---|---|
+8,96 % | 105 Mrd. | |
-1,43 % | 104 Mrd. | |
+4,40 % | 22,94 Mrd. | |
-12,15 % | 22,34 Mrd. | |
-4,36 % | 19,25 Mrd. | |
-39,98 % | 17,08 Mrd. | |
-10,04 % | 16,96 Mrd. | |
+6,79 % | 14,16 Mrd. | |
+38,61 % | 12,63 Mrd. |